​
​

vTv Therapeutics Ownership 2024 | Who Owns vTv Therapeutics Now?

OverviewForecastRevenueFinancialsChart

Institutional Ownership

4.23%

Insider Ownership

38.82%

Retail Ownership

56.96%

Institutional Holders

23.00

vTv Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----34-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----376-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----1,449-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----50,416-100.00%-Dec 31, 2023
STATE STREET CORP----134,745-100.00%-Dec 31, 2023
VANGUARD GROUP INC----939,623-100.00%-Dec 31, 2023
FMR LLC----7-100.00%-Dec 31, 2023
MORGAN STANLEY----33,442-100.00%-Dec 31, 2023
COMERICA BANK----1,000-100.00%-Dec 31, 2023
BNP PARIBAS ARBITRAGE, SNC----329-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----236,131-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----10,580-100.00%-Dec 31, 2023
BLACKROCK INC.----53,661-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----30,450-100.00%-Dec 31, 2023
FOCUSED WEALTH MANAGEMENT, INC----10,000-100.00%-Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.----4,000-100.00%-Dec 31, 2023
PARALLEL ADVISORS, LLC----1,500-100.00%-Dec 31, 2023
SIMON QUICK ADVISORS, LLC----30,000-100.00%-Dec 31, 2023
SAMSARA BIOCAPITAL, LLC----1,635,509-100.00%-Dec 31, 2023
CORNERSTONE PLANNING GROUP LLC----750-100.00%-Dec 31, 2023

vTv Therapeutics's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----34-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----376-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----1,449-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----50,416-100.00%-Dec 31, 2023
STATE STREET CORP----134,745-100.00%-Dec 31, 2023
VANGUARD GROUP INC----939,623-100.00%-Dec 31, 2023
FMR LLC----7-100.00%-Dec 31, 2023
MORGAN STANLEY----33,442-100.00%-Dec 31, 2023
COMERICA BANK----1,000-100.00%-Dec 31, 2023
BNP PARIBAS ARBITRAGE, SNC----329-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----236,131-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----10,580-100.00%-Dec 31, 2023
BLACKROCK INC.----53,661-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----30,450-100.00%-Dec 31, 2023
FOCUSED WEALTH MANAGEMENT, INC----10,000-100.00%-Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.----4,000-100.00%-Dec 31, 2023
PARALLEL ADVISORS, LLC----1,500-100.00%-Dec 31, 2023
SIMON QUICK ADVISORS, LLC----30,000-100.00%-Dec 31, 2023
SAMSARA BIOCAPITAL, LLC----1,635,509-100.00%-Dec 31, 2023
CORNERSTONE PLANNING GROUP LLC----750-100.00%-Dec 31, 2023

The largest vTv Therapeutics shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of vTv Therapeutics (VTVT), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC----7-100.00%-Dec 31, 2023
JPMORGAN CHASE & CO----34-100.00%-Dec 31, 2023
BNP PARIBAS ARBITRAGE, SNC----329-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----376-100.00%-Dec 31, 2023
CORNERSTONE PLANNING GROUP LLC----750-100.00%-Dec 31, 2023
COMERICA BANK----1,000-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----1,449-100.00%-Dec 31, 2023
PARALLEL ADVISORS, LLC----1,500-100.00%-Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.----4,000-100.00%-Dec 31, 2023
STRENGTHENING FAMILIES & COMMUNITIES, LLC----6,884-100.00%-Dec 31, 2023
FOCUSED WEALTH MANAGEMENT, INC----10,000-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----10,580-100.00%-Dec 31, 2023
SIMON QUICK ADVISORS, LLC----30,000-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----30,450-100.00%-Dec 31, 2023
MORGAN STANLEY----33,442-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----50,416-100.00%-Dec 31, 2023
BLACKROCK INC.----53,661-100.00%-Dec 31, 2023
STATE STREET CORP----134,745-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----236,131-100.00%-Dec 31, 2023
VANGUARD GROUP INC----939,623-100.00%-Dec 31, 2023

As of Dec 31 2023, vTv Therapeutics's largest institutional buyer is FMR LLC. The company purchased -7.00 stocks of VTVT, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SAMSARA BIOCAPITAL, LLC----1,635,509-100.00%-Dec 31, 2023
VANGUARD GROUP INC----939,623-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----236,131-100.00%-Dec 31, 2023
STATE STREET CORP----134,745-100.00%-Dec 31, 2023
BLACKROCK INC.----53,661-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----50,416-100.00%-Dec 31, 2023
MORGAN STANLEY----33,442-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----30,450-100.00%-Dec 31, 2023
SIMON QUICK ADVISORS, LLC----30,000-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----10,580-100.00%-Dec 31, 2023
FOCUSED WEALTH MANAGEMENT, INC----10,000-100.00%-Dec 31, 2023
STRENGTHENING FAMILIES & COMMUNITIES, LLC----6,884-100.00%-Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.----4,000-100.00%-Dec 31, 2023
PARALLEL ADVISORS, LLC----1,500-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----1,449-100.00%-Dec 31, 2023
COMERICA BANK----1,000-100.00%-Dec 31, 2023
CORNERSTONE PLANNING GROUP LLC----750-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----376-100.00%-Dec 31, 2023
BNP PARIBAS ARBITRAGE, SNC----329-100.00%-Dec 31, 2023
JPMORGAN CHASE & CO----34-100.00%-Dec 31, 2023

As of Dec 31 2023, vTv Therapeutics's biggest institutional seller is SAMSARA BIOCAPITAL, LLC. The company sold -1.64M shares of VTVT, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SAMSARA BIOCAPITAL, LLC----1,635,509-100.00%-Dec 31, 2023
VANGUARD GROUP INC----939,623-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----236,131-100.00%-Dec 31, 2023
STATE STREET CORP----134,745-100.00%-Dec 31, 2023
BLACKROCK INC.----53,661-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----50,416-100.00%-Dec 31, 2023
MORGAN STANLEY----33,442-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----30,450-100.00%-Dec 31, 2023
SIMON QUICK ADVISORS, LLC----30,000-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----10,580-100.00%-Dec 31, 2023
FOCUSED WEALTH MANAGEMENT, INC----10,000-100.00%-Dec 31, 2023
STRENGTHENING FAMILIES & COMMUNITIES, LLC----6,884-100.00%-Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.----4,000-100.00%-Dec 31, 2023
PARALLEL ADVISORS, LLC----1,500-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----1,449-100.00%-Dec 31, 2023
COMERICA BANK----1,000-100.00%-Dec 31, 2023
CORNERSTONE PLANNING GROUP LLC----750-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----376-100.00%-Dec 31, 2023
BNP PARIBAS ARBITRAGE, SNC----329-100.00%-Dec 31, 2023
JPMORGAN CHASE & CO----34-100.00%-Dec 31, 2023
FMR LLC----7-100.00%-Dec 31, 2023

vTv Therapeutics's largest sold out institutional shareholder by shares sold is SAMSARA BIOCAPITAL, LLC, sold -1.64M shares, valued at -, as of undefined.

vTv Therapeutics Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD EXPLORER FUND0.07%820,390--Jan 31, 2024
BRIDGEWAY FUNDS INC0.01%27,018--Mar 28, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%2,058--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.00%15,680--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%930,139--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%270,259--Feb 29, 2024
GPS Funds I0.00%5,694--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%30,946--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%615,945--Mar 31, 2024
Direxion Shares ETF Trust0.00%69,719--Jan 31, 2024
Calvert Variable Products, Inc.0.00%857--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%864--Mar 31, 2024
HC CAPITAL TRUST0.00%6,128--Mar 31, 2024
SunAmerica Specialty Series0.00%86--Apr 30, 2021
TIAA-CREF FUNDS0.00%477,065--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%406--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%24,320-6,615-21.38%Mar 31, 2024
NORTHERN FUNDS0.00%6,173--Mar 28, 2024
FIDELITY SALEM STREET TRUST0.00%153,083--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%5,414-10-0.18%Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%1,500--Mar 31, 2024
ProFunds0.00%257--Mar 31, 2024
VALIC Co I0.00%5,625--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%36,453--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%1,897--Mar 31, 2024
ALLSPRING MASTER TRUST0.00%819--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%1,455--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%1,250--Jan 31, 2024
T. Rowe Price Index Trust, Inc.0.00%98--Feb 29, 2024
EQ ADVISORS TRUST0.00%4,244--Mar 31, 2024
SUNAMERICA SERIES TRUST0.00%1,282--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%1,420--Dec 31, 2023
Bridge Builder Trust0.00%4,994--Mar 31, 2024
iSHARES TRUST0.00%8,976--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%1,048--Mar 31, 2024
PACIFIC SELECT FUND0.00%1,078--Mar 31, 2024
BlackRock Variable Series Funds, Inc.0.00%1,176--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%1,276--Feb 29, 2024

vTv Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD EXPLORER FUND", owning 820.39K shares, compromising 0.07% of its total assets.

vTv Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 232321.05%
30 Jun, 2319-17.39%
31 Mar, 2323-20.69%
31 Dec, 222920.83%
30 Sep, 222414.29%
30 Jun, 2221-8.70%
31 Mar, 2223-20.69%
31 Dec, 21293.57%
30 Sep, 2128-28.21%
30 Jun, 2139-15.22%
31 Mar, 21469.52%
31 Dec, 20425.00%
30 Sep, 20402.56%
30 Jun, 203956.00%
31 Mar, 202531.58%
31 Dec, 1919-
30 Sep, 1919-5.00%
30 Jun, 19205.26%
31 Mar, 19195.56%
31 Dec, 181812.50%
30 Sep, 1816-42.86%
30 Jun, 1828-28.21%
31 Mar, 1839-2.50%
31 Dec, 174014.29%
30 Sep, 1735-7.89%
30 Jun, 1738-7.32%
31 Mar, 1741-6.82%
31 Dec, 164425.71%
30 Sep, 1635-
30 Jun, 1635-14.63%
31 Mar, 1641-
31 Dec, 154113.89%
30 Sep, 1536-

As of 30 Sep 23, 23 institutions are holding vTv Therapeutics's shares, representing an increase of 21.05% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 233,444,101-2.04%
30 Jun, 233,515,939-1.48%
31 Mar, 233,568,739-4.38%
31 Dec, 223,732,3126.88%
30 Sep, 223,492,090-4.29%
30 Jun, 223,648,681-30.02%
31 Mar, 225,213,801-21.20%
31 Dec, 216,616,85595.48%
30 Sep, 213,384,921-21.59%
30 Jun, 214,316,804-9.08%
31 Mar, 214,748,08692.20%
31 Dec, 202,470,434-39.07%
30 Sep, 204,054,73112.57%
30 Jun, 203,601,90854.96%
31 Mar, 202,324,428166.79%
31 Dec, 19871,262-71.61%
30 Sep, 193,069,249243.86%
30 Jun, 19892,59817.38%
31 Mar, 19760,42146.80%
31 Dec, 18517,98711.28%
30 Sep, 18465,485-42.69%
30 Jun, 18812,177-83.55%
31 Mar, 184,936,89834.37%
31 Dec, 173,674,2127.46%
30 Sep, 173,419,018-5.69%
30 Jun, 173,625,2480.14%
31 Mar, 173,620,337-3.13%
31 Dec, 163,737,184-8.19%
30 Sep, 164,070,539-3.40%
30 Jun, 164,213,906-10.58%
31 Mar, 164,712,546-4.65%
31 Dec, 154,942,201-1.32%
30 Sep, 155,008,493-

vTv Therapeutics (VTVT) has 3.44M shares outstanding as of 30 Sep 23, down -2.04% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 234.23%22.70%
30 Jun, 234.31%22.49%
31 Mar, 234.38%6.99%
31 Dec, 227.92%14.43%
30 Sep, 227.41%27.55%
30 Jun, 225.19%8.55%
31 Mar, 227.79%6.56%
31 Dec, 2110.90%35.47%
30 Sep, 215.54%10.22%
30 Jun, 217.36%10.42%
31 Mar, 218.41%36.02%
31 Dec, 204.83%6.84%
30 Sep, 208.41%13.51%
30 Jun, 207.89%27.58%
31 Mar, 205.35%64.65%
31 Dec, 192.88%3.15%
30 Sep, 199.55%94.26%
30 Jun, 193.18%28.78%
31 Mar, 193.33%19.21%
31 Dec, 184.16%29.08%
30 Sep, 183.78%5.79%
30 Jun, 188.08%0.31%
31 Mar, 1850.90%3.54%
31 Dec, 1737.90%3.05%
30 Sep, 1735.27%2.52%
30 Jun, 1737.40%2.68%
31 Mar, 1737.35%2.44%
31 Dec, 1639.15%2.22%
30 Sep, 1642.00%2.16%
30 Jun, 1644.06%1.69%
31 Mar, 1651.06%1.75%
31 Dec, 1553.97%1.48%
30 Sep, 1560.30%-

As of 30 Sep 23, vTv Therapeutics is held by 4.23% institutional shareholders, representing a 22.70% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 23833.33%
30 Jun, 23620.00%
31 Mar, 235-58.33%
31 Dec, 221250.00%
30 Sep, 228-
30 Jun, 228100.00%
31 Mar, 224-71.43%
31 Dec, 211416.67%
30 Sep, 2112-36.84%
30 Jun, 2119-40.63%
31 Mar, 213223.08%
31 Dec, 202623.81%
30 Sep, 2021-36.36%
30 Jun, 2033106.25%
31 Mar, 2016128.57%
31 Dec, 19716.67%
30 Sep, 196-25.00%
30 Jun, 198-20.00%
31 Mar, 191011.11%
31 Dec, 18980.00%
30 Sep, 185-66.67%
30 Jun, 1815-25.00%
31 Mar, 1820-9.09%
31 Dec, 172283.33%
30 Sep, 1712-20.00%
30 Jun, 1715-21.05%
31 Mar, 1719-17.39%
31 Dec, 162343.75%
30 Sep, 1616-
30 Jun, 1616-20.00%
31 Mar, 1620-9.09%
31 Dec, 1522-38.89%
30 Sep, 1536-

8 institutional shareholders have increased their position in VTVT stock as of 30 Sep 23 compared to 6 in the previous quarter (a 33.33% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 234300.00%
30 Jun, 231-85.71%
31 Mar, 237-
31 Dec, 22740.00%
30 Sep, 225-16.67%
30 Jun, 226-33.33%
31 Mar, 229-
31 Dec, 219-
30 Sep, 219-47.06%
30 Jun, 211788.89%
31 Mar, 21928.57%
31 Dec, 207-36.36%
30 Sep, 2011175.00%
30 Jun, 204-42.86%
31 Mar, 20716.67%
31 Dec, 196-
30 Sep, 19620.00%
30 Jun, 19566.67%
31 Mar, 193-40.00%
31 Dec, 185-16.67%
30 Sep, 186-40.00%
30 Jun, 1810-
31 Mar, 1810-9.09%
31 Dec, 1711-
30 Sep, 1711-8.33%
30 Jun, 1712-29.41%
31 Mar, 1717112.50%
31 Dec, 16833.33%
30 Sep, 166-
30 Jun, 166-45.45%
31 Mar, 1611-15.38%
31 Dec, 1513-
30 Sep, 15--

4 institutional shareholders have reduced their position in VTVT stock as of 30 Sep 23 compared to 1 in the previous quarter (a 300.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 232321.05%3,444,101-2.04%4.23%22.70%833.33%4300.00%
30 Jun, 2319-17.39%3,515,939-1.48%4.31%22.49%620.00%1-85.71%
31 Mar, 2323-20.69%3,568,739-4.38%4.38%6.99%5-58.33%7-
31 Dec, 222920.83%3,732,3126.88%7.92%14.43%1250.00%740.00%
30 Sep, 222414.29%3,492,090-4.29%7.41%27.55%8-5-16.67%
30 Jun, 2221-8.70%3,648,681-30.02%5.19%8.55%8100.00%6-33.33%
31 Mar, 2223-20.69%5,213,801-21.20%7.79%6.56%4-71.43%9-
31 Dec, 21293.57%6,616,85595.48%10.90%35.47%1416.67%9-
30 Sep, 2128-28.21%3,384,921-21.59%5.54%10.22%12-36.84%9-47.06%
30 Jun, 2139-15.22%4,316,804-9.08%7.36%10.42%19-40.63%1788.89%
31 Mar, 21469.52%4,748,08692.20%8.41%36.02%3223.08%928.57%
31 Dec, 20425.00%2,470,434-39.07%4.83%6.84%2623.81%7-36.36%
30 Sep, 20402.56%4,054,73112.57%8.41%13.51%21-36.36%11175.00%
30 Jun, 203956.00%3,601,90854.96%7.89%27.58%33106.25%4-42.86%
31 Mar, 202531.58%2,324,428166.79%5.35%64.65%16128.57%716.67%
31 Dec, 1919-871,262-71.61%2.88%3.15%716.67%6-
30 Sep, 1919-5.00%3,069,249243.86%9.55%94.26%6-25.00%620.00%
30 Jun, 19205.26%892,59817.38%3.18%28.78%8-20.00%566.67%
31 Mar, 19195.56%760,42146.80%3.33%19.21%1011.11%3-40.00%
31 Dec, 181812.50%517,98711.28%4.16%29.08%980.00%5-16.67%
30 Sep, 1816-42.86%465,485-42.69%3.78%5.79%5-66.67%6-40.00%
30 Jun, 1828-28.21%812,177-83.55%8.08%0.31%15-25.00%10-
31 Mar, 1839-2.50%4,936,89834.37%50.90%3.54%20-9.09%10-9.09%
31 Dec, 174014.29%3,674,2127.46%37.90%3.05%2283.33%11-
30 Sep, 1735-7.89%3,419,018-5.69%35.27%2.52%12-20.00%11-8.33%
30 Jun, 1738-7.32%3,625,2480.14%37.40%2.68%15-21.05%12-29.41%
31 Mar, 1741-6.82%3,620,337-3.13%37.35%2.44%19-17.39%17112.50%
31 Dec, 164425.71%3,737,184-8.19%39.15%2.22%2343.75%833.33%
30 Sep, 1635-4,070,539-3.40%42.00%2.16%16-6-
30 Jun, 1635-14.63%4,213,906-10.58%44.06%1.69%16-20.00%6-45.45%
31 Mar, 1641-4,712,546-4.65%51.06%1.75%20-9.09%11-15.38%
31 Dec, 154113.89%4,942,201-1.32%53.97%1.48%22-38.89%13-
30 Sep, 1536-5,008,493-60.30%-36---

vTv Therapeutics Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-D-ReturnSell52,881--89,254
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-D-ReturnSell4,776--8,060

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 27, 2024BAKER BROS. ADVISORS LPdirector-A-AwardBuy6,000$17.22$103.32K6,000
Jun 27, 2024BAKER BROS. ADVISORS LPdirector-A-AwardBuy983$17.22$16.93K983
Jun 27, 2024SPIEGELMAN DANIEL Kdirector-A-AwardBuy6,000$17.22$103.32K6,000
Jun 27, 2024Al-Marzooqi Faheddirector-A-AwardBuy3,000$17.22$51.66K9,555
Jun 27, 2024Phillips Anne M.director-A-AwardBuy860$17.22$14.81K6,860
Jun 27, 2024Phillips Anne M.director-A-AwardBuy2,250$17.22$38.74K6,000
Jun 13, 2024AKKARAJU SRINIVASdirector, 10 percent owner A-AwardBuy3,750$8.50$31.88K3,750
Jun 13, 2024Al-Marzooqi Faheddirector-A-AwardBuy4,055$11.81$47.89K6,555
Jun 13, 2024SEKHRI PAUL Jdirector, officer President and CEOA-AwardBuy89,212$11.81$1.05M144,212
Jun 13, 2024Tuch Steven L.officer Chief Financial OfficerA-AwardBuy62,159$11.81$734.10K74,659
Jun 13, 2024Phillips Anne M.director-A-AwardBuy3,750$16.04$60.15K3,750
Jun 13, 2024SPIEGELMAN DANIEL Kdirector Buy----
Mar 14, 2024Phillips Anne M.director Buy----
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-A-AwardBuy52,925$0.01$529.252,823,061
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-A-AwardBuy4,780$0.01$47.80254,948
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-D-ReturnSell52,881--89,254
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-D-ReturnSell4,776--8,060
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-Buy---142,135
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-Buy---12,836
Mar 07, 2024BAKER BROS. ADVISORS LPdirector-Buy2,770,136$0.01$27.70K-

The last insider sell of vTv Therapeutics's stock was made by BAKER BROS. ADVISORS LP on Mar 07 2024, selling 52,881 shares at - per share (valued at -).

vTv Therapeutics Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20246--
Q1 202492450.00%
Q2 20236--
Q4 20223--
Q3 20221011000.00%
Q2 2022-1-
Q1 20221616.67%
Q4 202111100.00%
Q2 20217--
Q1 20213--
Q4 20206966.67%
Q3 2020-1-
Q2 202072350.00%
Q1 20204757.14%
Q4 201988100.00%
Q3 2019111291.67%
Q2 201954125.00%
Q1 2019109111.11%
Q4 20185683.33%
Q3 20187887.50%

6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by vTv Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024---
Q2 2023---
Q4 20222--
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021-1-
Q2 2021---
Q1 20213--
Q4 20203--
Q3 2020---
Q2 20202--
Q1 20203--
Q4 20194--
Q3 20199--
Q2 20192--
Q1 20194--
Q4 20183--
Q3 20185--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of vTv Therapeutics's stocks.

vTv Therapeutics Peer Ownership

TickerCompany
GOVXGeoVax Labs, Inc.
INMInMed Pharmaceuticals Inc.
EWTXEdgewise Therapeutics, Inc.
ERASErasca, Inc.
PHIOPhio Pharmaceuticals Corp.
GBIOGeneration Bio Co.
QNRXQuoin Pharmaceuticals, Ltd.
HILSTharimmune, Inc.
SGTXSigilon Therapeutics, Inc.
KRONKronos Bio, Inc.
VRAXVirax Biolabs Group Limited
CCCCC4 Therapeutics, Inc.
EFTReFFECTOR Therapeutics, Inc.
ALLRAllarity Therapeutics, Inc.
IMMXImmix Biopharma, Inc.
CYTOAltamira Therapeutics Ltd.
NRBONeuroBo Pharmaceuticals, Inc.
PYXSPyxis Oncology, Inc.
ZURAZura Bio Limited
ELEVElevation Oncology, Inc.

VTVT Ownership FAQ

vTv Therapeutics is owned by institutional shareholders (4.23%), insiders (38.82%), and public (56.96%). The largest institutional shareholder of vTv Therapeutics is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is VANGUARD EXPLORER FUND (0.07% of total shares).

vTv Therapeutics's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.

As of Sep 2023, there are 23 institutional shareholders of vTv Therapeutics.

JPMORGAN CHASE & CO owns 0 shares of vTv Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

As of Dec 2023, BANK OF AMERICA CORP /DE/ holds 0 shares of vTv Therapeutics (VTVT), compromising 0% of the company, valued at $0.

WELLS FARGO & COMPANY/MN is the third largest holder of vTv Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).